Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

C5 anticorps

Cet anticorps anti-C5 est un anticorps Souris Monoclonal détectant C5 dans IA. Adapté pour Humain. Ce Primary Antibody a été cité dans 2+ publications.
N° du produit ABIN2191947

Aperçu rapide pour C5 anticorps (ABIN2191947)

Antigène

Voir toutes C5 Anticorps
C5 (Complement Component 5 (C5))

Reactivité

  • 125
  • 33
  • 23
  • 16
  • 2
  • 2
  • 2
Humain

Hôte

  • 114
  • 22
  • 4
  • 3
Souris

Clonalité

  • 122
  • 21
Monoclonal

Conjugué

  • 57
  • 13
  • 12
  • 8
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp C5 est non-conjugé

Application

  • 77
  • 50
  • 44
  • 39
  • 35
  • 18
  • 13
  • 11
  • 11
  • 10
  • 7
  • 5
  • 4
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Immunoassay (IA)

Clone

561
  • Stérilité

    0.2 μm filtered
  • Indications d'application

    The dilutions to be used depend on detection system applied. It is recommended that users test the reagent and determine their own optimal dilutions. The typical starting working dilution is 1:50. For functional studies, in vitro dilutions have to be optimized in user's experimental setting.

    Restrictions

    For Research Use only
  • Buffer

    PBS, containing 0.1 % bovine serum albumin.

    Stock

    4 °C

    Stockage commentaire

    Product should be stored at 4 °C. Under recommended storage conditions, product is stable for at least one year. The exact expiry date is indicated on the label.
  • Fung, Lu, Fure, Sun, Sun, Shi, Dou, Su, Swanson, Mollnes: "Pre-neutralization of C5a-mediated effects by the monoclonal antibody 137-26 reacting with the C5a moiety of native C5 without preventing C5 cleavage." dans: Clinical and experimental immunology, Vol. 133, Issue 2, pp. 160-9, (2003) (PubMed).

    Mollnes, Brekke, Fung, Fure, Christiansen, Bergseth, Videm, Lappegård, Köhl, Lambris: "Essential role of the C5a receptor in E coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation." dans: Blood, Vol. 100, Issue 5, pp. 1869-77, (2002) (PubMed).

  • Antigène

    C5 (Complement Component 5 (C5))

    Autre désignation

    c5/c5a

    Sujet

    Monoclonal antibody 561 recognizes the N-terminus of C5. The antibody reacts both with intact C5 (190 kDa) as with C5a (115 kDa). The complement system is composed of over 30 proteins, activated in response to tissue injury, invading pathogens or other foreign surfaces. The complement pathways can be divided in the activation pathways and lytic pathway. The activation pathways lead via C3 to the cleavage of the fifth complement component C5 into C5a and C5b, resulting in activation of the lytic pahway C5a was first described as a cleavage product of C5 with chemotactic and anaphylatoxic properties. Further characterization revealed that C5a is an essential part of the innate immune response and evidence now suggests that it may also play a role in adaptive immunity. Complement fragment C5a is a 74 residue pro-inflammatory polypeptide. C5a induces smooth muscle contraction, increases vascular permeability, causes degranulation of mast cells and basophils, and release of lysosomal enzymes. In addition C5a stimulates the directed migration of neutrophils, eosinophils, basophils and monocytes. C5a binds to at least two seven-transmembrane domain receptors, C5aR (C5R1, CD88) and C5L2 (gpr77), expressed ubiquitously on a wide variety of cells but particularly on the surface of immune cells like macrophages, neutrophils and T cells. The former is a well-established receptor that initiates G-protein-coupled signaling via mitogen-activated protein kinase pathways, thereby by inducing synthesis of cytokines such as TNF-alpha, IL-1beta, IL-6 and IL-8. Its in vivo blockade greatly reduces inflammatory injury. Much less is known about C5L2, occupancy of which by C5a does not initiate increased intracellular Ca(2+).The widespread expression of C5a receptors throughout the body allows C5a to elicit a broad range of effects. Thus, C5a has been found to be a significant pathogenic driver in a number of immuno-inflammatory diseases. Nowadays C5a is also implicated in non-immunological functions associated with developmental biology, CNS development and neurodegeneration, tissue regeneration, and haematopoiesis. Immunogen Human C5/C5a

    Pathways

    Système du Complément, Carbohydrate Homeostasis
Vous êtes ici:
Chat with us!